Drug Shortage Report for MYLAN-BUDESONIDE AQ
Report ID | 23169 |
Drug Identification Number | 02241003 |
Brand name | MYLAN-BUDESONIDE AQ |
Common or Proper name | BUDESONIDE AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 64MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 120 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-10-30 |
Actual start date | 2018-11-05 |
Estimated end date | 2020-03-03 |
Actual end date | 2020-03-03 |
Shortage status | Resolved |
Updated date | 2020-03-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v75 | 2019-01-15 | English | Compare |
v74 | 2018-12-19 | French | Compare |
v73 | 2018-12-19 | English | Compare |
v72 | 2018-11-20 | French | Compare |
v71 | 2018-11-20 | English | Compare |
v70 | 2018-11-06 | French | Compare |
v69 | 2018-11-06 | English | Compare |
v68 | 2018-10-31 | English | Compare |
v67 | 2018-10-29 | French | Compare |
v66 | 2018-10-29 | English | Compare |
v65 | 2018-10-29 | French | Compare |
v64 | 2018-10-29 | English | Compare |
v63 | 2018-10-23 | French | Compare |
v62 | 2018-10-23 | English | Compare |
v61 | 2018-09-13 | French | Compare |
v60 | 2018-09-13 | English | Compare |
v59 | 2018-09-10 | French | Compare |
v58 | 2018-09-10 | English | Compare |
v57 | 2018-08-01 | French | Compare |
v56 | 2018-08-01 | English | Compare |